A genetically immortalized human stem cell line: a promising new tool for Alzheimer's disease therapy
Open Access
- 21 October 2015
- journal article
- research article
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 14, 1135-1114
Abstract
Amyloid-β peptides and hyper-phosphorylated tau are the main pathological hallmarks of Alzheimer's disease (AD). Given the recent failure of several large-scale clinical trials and the lack of disease-modifying pharmacological treatments, there is an urgent need to develop alternative therapies. A clinical grade human CTX0E03 neural stem cell line has recently passed phase I trials in people with stroke. However, this cell line has not been investigated in other neurodegenerative disorders. This study investigates the survival of CTX0E03 cells under conditions based on the underlying AD pathology. Cell viability assays showed a concentration dependence of this cell line to the toxic effects of Aβ1-42, but not Aβ1-40, and okadaic acid, a phosphatase 2A inhibitor. Notably, CTX0E03 cell line displayed toxicity at concentrations significantly higher than both rat neural stem cells and those previously reported for primary cultures. These results suggest CTX0E03 cells could be developed for clinical trials in AD patients.Keywords
This publication has 50 references indexed in Scilit:
- Human Neural Progenitor Cell Engraftment Increases Neurogenesis and Microglial Recruitment in the Brain of Rats with StrokePLOS ONE, 2012
- Concise Review: Can Stem Cells be Used to Treat or Model Alzheimer's Disease?Stem Cells, 2012
- Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicityCell Death & Disease, 2012
- Implantation Site and Lesion Topology Determine Efficacy of a Human Neural Stem Cell Line in a Rat Model of Chronic StrokeStem Cells, 2012
- Adult hippocampal neurogenesis and its role in Alzheimer's diseaseMolecular Neurodegeneration, 2011
- Neurogenesis in mouse models of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrilsNature Structural & Molecular Biology, 2010
- Structure–neurotoxicity relationships of amyloid β-protein oligomersProceedings of the National Academy of Sciences, 2009
- Neurogenesis and cell cycle‐reactivated neuronal death during pathogenic tau aggregationGenes, Brain and Behavior, 2008
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology and Medicine, 2007